4
Changes in Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0000899243-20-025165
Options or other derivatives
- Director acquired 1,167.21 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McBride John S. Director | 2020-09-11 | Grant or award · Stock Option (Right to Buy) | +1,167.21 | 1,167.21 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…